pI: 6.3531 |
Length (AA): 470 |
MW (Da): 51829 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
2 | 462 | 3cb2 (A) | 2 | 446 | 27.00 | 0 | 1 | 1.24995 | -0.51 |
2 | 448 | 3cb2 (A) | 2 | 435 | 32.00 | 0 | 1 | 1.23286 | -0.51 |
3 | 457 | 4i4t (D) | 2 | 441 | 30.00 | 0 | 1 | 1.34619 | -0.9 |
3 | 448 | 1ffx (B) | 2 | 432 | 34.00 | 0 | 1 | 1.16774 | 0.42 |
3 | 456 | 4u3j (B) | 2 | 430 | 28.00 | 0 | 1 | 1.28606 | -0.92 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_130726)
Species | Accession | Gene Product |
---|---|---|
Echinococcus granulosus | EgrG_000603100 | tubulin epsilon chain |
Echinococcus multilocularis | EmuJ_000603100 | tubulin epsilon chain |
Giardia lamblia | GL50803_6336 | Epsilon tubulin |
Homo sapiens | ENSG00000074935 | tubulin, epsilon 1 |
Leishmania braziliensis | LbrM.21.1240 | epsilon tubulin, putative |
Leishmania donovani | LdBPK_211250.1 | epsilon tubulin, putative |
Leishmania infantum | LinJ.21.1250 | epsilon tubulin, putative |
Leishmania major | LmjF.21.1010 | epsilon tubulin, putative |
Leishmania mexicana | LmxM.21.1010 | epsilon tubulin, putative |
Mus musculus | ENSMUSG00000019845 | epsilon-tubulin 1 |
Neospora caninum | NCLIV_007070 | tubulin epsilon chain, putative |
Plasmodium berghei | PBANKA_1300500 | tubulin epsilon chain, putative |
Plasmodium falciparum | PF3D7_1475700 | tubulin epsilon chain, putative |
Plasmodium knowlesi | PKNH_1246000 | tubulin epsilon chain, putative |
Plasmodium vivax | PVX_118660 | tubulin epsilon chain, putative |
Plasmodium yoelii | PY05777 | tubulin beta chain |
Schistosoma japonicum | Sjp_0009290 | ko:K10391 tubulin epsilon, putative |
Schistosoma mansoni | Smp_028360 | tubulin subunit epsilon |
Schmidtea mediterranea | mk4.013167.01 | Tubulin epsilon chain |
Schmidtea mediterranea | mk4.013167.02 | Tubulin epsilon chain, putative |
Schmidtea mediterranea | mk4.016956.01 | Tubulin epsilon chain, putative |
Schmidtea mediterranea | mk4.023212.00 | Tubulin epsilon chain, putative |
Schmidtea mediterranea | mk4.016956.00 | |
Trypanosoma brucei gambiense | Tbg972.10.1240 | epsilon tubulin |
Trypanosoma brucei | Tb927.10.1140 | epsilon tubulin |
Trypanosoma brucei | Tb11.0530 | epsilon tubulin |
Trypanosoma congolense | TcIL3000_10_940 | epsilon tubulin |
Trypanosoma cruzi | TcCLB.509967.160 | epsilon tubulin, putative |
Trypanosoma cruzi | TcCLB.509695.120 | epsilon tubulin, putative |
Toxoplasma gondii | TGME49_275970 | tubulin, putative |
Toxoplasma gondii | TGME49_275870 | tubulin/FtsZ family, GTPase domain-containing protein |
Trichomonas vaginalis | TVAG_065740 | tubulin gamma chain, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.1140 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.1140 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.1140 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.1140 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
PBANKA_1300500 | Plasmodium berghei | Dispensable | plasmo |
TGME49_275870 | Toxoplasma gondii | Probably non-essential | sidik |
TGME49_275970 | Toxoplasma gondii | Probably non-essential | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Leishmania major | epsilon tubulin, putative | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Leishmania major | alpha tubulin | 451 aa | 27.2% | 474 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 27.2% | 474 aa | Compounds | References |
Sus scrofa | Tubulin | 445 aa | 30.1% | 475 aa | Compounds | References |
Trypanosoma brucei | beta tubulin | 442 aa | 30.0% | 460 aa | Compounds | References |
Sus scrofa | Tubulin alpha chain | 451 aa | 27.0% | 471 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 30.8% | 458 aa | Compounds | References |
Ovis aries | Tubulin alpha 4a | 448 aa | 27.4% | 471 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 27.2% | 474 aa | Compounds | References |
Leishmania major | gamma-tubulin | 447 aa | 29.5% | 451 aa | Compounds | References |
Trypanosoma brucei | alpha tubulin | 451 aa | 27.9% | 474 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 30.8% | 458 aa | Compounds | References |
Rattus norvegicus | Tubulin alpha-1 chain | 451 aa | 27.0% | 471 aa | Compounds | References |
Trypanosoma brucei | alpha tubulin | 451 aa | 27.9% | 474 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 30.8% | 458 aa | Compounds | References |
Trypanosoma brucei | alpha tubulin | 451 aa | 27.9% | 474 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 27.2% | 474 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 27.2% | 474 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 27.2% | 474 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 30.8% | 458 aa | Compounds | References |
Plasmodium falciparum | tubulin beta chain | 445 aa | 30.5% | 466 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 27.2% | 474 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 30.8% | 458 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 30.8% | 458 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 27.2% | 474 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 30.8% | 458 aa | Compounds | References |
Trypanosoma brucei | tubulin gamma chain | 447 aa | 28.4% | 478 aa | Compounds | References |
Bos taurus | Tubulin beta chain | 445 aa | 30.3% | 475 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 27.2% | 474 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 27.2% | 474 aa | Compounds | References |
Bos taurus | Tubulin | 85 aa | 28.2% | 110 aa | Compounds | References |
Bos taurus | Tubulin | 445 aa | 30.3% | 475 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 30.8% | 458 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 30.8% | 458 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 30.8% | 458 aa | Compounds | References |
Trypanosoma brucei | alpha tubulin | 451 aa | 27.9% | 474 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 30.8% | 458 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 30.8% | 458 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 30.8% | 458 aa | Compounds | References |
Plasmodium falciparum | alpha tubulin 1 | 453 aa | 28.3% | 474 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 27.2% | 474 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 30.8% | 458 aa | Compounds | References |
Leishmania major | beta tubulin | 443 aa | 30.8% | 458 aa | Compounds | References |
Leishmania major | alpha tubulin | 451 aa | 27.2% | 474 aa | Compounds | References |